IL91335A0 - Dna sequence and hepadnavirus - Google Patents
Dna sequence and hepadnavirusInfo
- Publication number
- IL91335A0 IL91335A0 IL91335A IL9133589A IL91335A0 IL 91335 A0 IL91335 A0 IL 91335A0 IL 91335 A IL91335 A IL 91335A IL 9133589 A IL9133589 A IL 9133589A IL 91335 A0 IL91335 A0 IL 91335A0
- Authority
- IL
- Israel
- Prior art keywords
- hepadnavirus
- dna sequence
- dna
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23281188A | 1988-08-16 | 1988-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL91335A0 true IL91335A0 (en) | 1990-03-19 |
Family
ID=22874695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL91335A IL91335A0 (en) | 1988-08-16 | 1989-08-16 | Dna sequence and hepadnavirus |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0380656A1 (xx) |
AU (1) | AU4315689A (xx) |
DK (1) | DK93390A (xx) |
FI (1) | FI901876A0 (xx) |
IE (1) | IE892640L (xx) |
IL (1) | IL91335A0 (xx) |
WO (1) | WO1990002176A1 (xx) |
ZA (1) | ZA896246B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0528903B1 (en) * | 1990-04-20 | 1996-09-11 | The General Hospital Corporation | Methods of preventing viral replication |
US5610050A (en) * | 1990-04-20 | 1997-03-11 | The General Hospital Corporation | Methods of preventing viral replication |
FR2716459B1 (fr) * | 1994-02-22 | 1996-05-10 | Univ Paris Curie | Système hôte-vecteur utilisable en thérapie génique. |
US5869248A (en) * | 1994-03-07 | 1999-02-09 | Yale University | Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
US5683873A (en) * | 1995-01-13 | 1997-11-04 | Innovir Laboratories, Inc. | EGS-mediated inactivation of target RNA |
US6057153A (en) * | 1995-01-13 | 2000-05-02 | Yale University | Stabilized external guide sequences |
DE19517532C2 (de) | 1995-05-12 | 1999-10-28 | Max Planck Gesellschaft | HBV-Vektoren und Zellen zu ihrer Bereitstellung |
WO1998011916A1 (en) * | 1996-09-18 | 1998-03-26 | The Board Of Regents Of The University Of Texas System | Viral defective interfering particles and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861588A (en) * | 1985-02-05 | 1989-08-29 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
-
1989
- 1989-08-16 IL IL91335A patent/IL91335A0/xx unknown
- 1989-08-16 AU AU43156/89A patent/AU4315689A/en not_active Abandoned
- 1989-08-16 EP EP89910500A patent/EP0380656A1/en not_active Withdrawn
- 1989-08-16 ZA ZA896246A patent/ZA896246B/xx unknown
- 1989-08-16 WO PCT/US1989/003521 patent/WO1990002176A1/en not_active Application Discontinuation
- 1989-08-16 IE IE892640A patent/IE892640L/xx unknown
-
1990
- 1990-04-11 DK DK093390A patent/DK93390A/da not_active Application Discontinuation
- 1990-04-12 FI FI901876A patent/FI901876A0/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE892640L (en) | 1990-02-16 |
AU4315689A (en) | 1990-03-23 |
DK93390A (da) | 1990-06-15 |
DK93390D0 (da) | 1990-04-11 |
EP0380656A1 (en) | 1990-08-08 |
FI901876A0 (fi) | 1990-04-12 |
WO1990002176A1 (en) | 1990-03-08 |
ZA896246B (en) | 1990-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU904853D0 (en) | Enzymes and their use | |
GB2183886B (en) | Microbook and its associated bookgenerator unit | |
EP0355247A3 (en) | Compressed-molded preparations | |
GB2210043B (en) | Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides | |
EP0204659A3 (en) | Polyepoxydes and their use | |
GR860078B (en) | Spiro - dioxolanes - dithiolanes and oxothiolanes | |
GB8724412D0 (en) | Protein | |
EP0313969A3 (en) | Tripeptide derivatives and antiplasmin agents containing the same | |
DE3660256D1 (en) | Camphor-di-thiolene-complexes and their use | |
EP0255801A3 (en) | Anilinotriazines and their use | |
IL91335A0 (en) | Dna sequence and hepadnavirus | |
ZA894800B (en) | Proteins and nucleic acids | |
HUT54932A (en) | Shear insert and insert-holding arrangement | |
NZ227594A (en) | Human interleukin-1alpha and preparations thereof | |
EP0465132A3 (en) | Dna and its use | |
EP0316934A3 (en) | Muramyl peptide derivatives and use thereof | |
ZA895461B (en) | Modified proteins | |
GB8818150D0 (en) | Gene modification | |
GB8816095D0 (en) | Protein | |
KR910007551B1 (en) | Polyethylene terephchalate and its use | |
EP0233740A3 (en) | Aerocavin and aerocyanidin - antibiotics | |
EP0207700A3 (en) | Hypocholesterolemically and/or hypotriclyceridemically active rna fractions | |
JPS6425789A (en) | Substituted amidephophonate and amidephosphate | |
IL92606A0 (en) | Sphingenine and derivatives thereof | |
CS976187A1 (en) | Oxigen-bridged tetrahydropyridines- parimidines and hexahydropyridines |